{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:08:45Z","timestamp":1776330525964,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13003-4","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:37:33Z","timestamp":1773070653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pattern of treatment outcome and safety of prednisolone in the treatment of leprosy reactions among leprosy patients in ALERT hospital: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Gemechis Mikael","family":"Mamo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samrawit Solomon","family":"Ethiopia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tolesa Diriba","family":"Biratu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Legese","family":"Achalu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"13003_CR1","first-page":"106","volume":"1","author":"E Cooreman","year":"2018","unstructured":"Cooreman E, Gillini L, Pemmaraju V, Shridar M, Tisocki K, Ahmed J, et al. Guidelines for the diagnosis, Treatment and Prevention of Leprosy. World Heal Organ. 2018;1:106.","journal-title":"World Heal Organ"},{"key":"13003_CR2","unstructured":"Al-Qubati Y, Beise K, Castalia R, Cambau E, Cauchoix B. Global Leprosy Strategy 2016\u20132020. 2020. 102 p."},{"key":"13003_CR3","unstructured":"Health FDR of EM of Ethiopia - National Strategic Plan Tuberculosis and Leprosy Control 2013\u20132020. Moh. 2017;13(November 2017):92."},{"issue":"9","key":"13003_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1371\/journal.pntd.0000425","volume":"3","author":"C Franco-Paredes","year":"2009","unstructured":"Franco-Paredes C, Jacob JT, Stryjewska B, Yoder L. Two patients with leprosy and the sudden appearance of inflammation in the skin and new sensory loss. PLoS Negl Trop Dis. 2009;3(9):2\u20136.","journal-title":"PLoS Negl Trop Dis"},{"key":"13003_CR5","unstructured":"WHO. Report of Treatment of Reactions and Prevention of Disabilities. 2019;(December 2018):1\u201344. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/325146\/sea-glp-2019.1-eng.pdf?sequence=1&isAllowed=y"},{"issue":"5","key":"13003_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1590\/abd1806-4841.20132004","volume":"88","author":"JA Nery","year":"2013","unstructured":"Nery JA, da Machado C, Bernardes Filho AM, Oliveira F, de SC S, Quintanilha J, Sales AM. Compreender melhor o estado reacional tipo 1 para o diagn\u00f3stico e tratamento precoces: Uma forma de se evitar as incapacidades na hansen\u00edase. Bras Dermatol. 2013;88(5):787\u201392.","journal-title":"Bras Dermatol"},{"key":"13003_CR7","doi-asserted-by":"crossref","unstructured":"Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev [Internet]. 2006 Apr [cited 2022 Feb 9];19(2):338\u201381. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16614253\/","DOI":"10.1128\/CMR.19.2.338-381.2006"},{"key":"13003_CR8","doi-asserted-by":"crossref","unstructured":"Walker SL, Lebas E, Doni SN, Lockwood DNJ, Lambert SM. The mortality associated with erythema nodosum leprosum in Ethiopia: a retrospective hospital-based study. PLoS Negl Trop Dis [Internet]. 2014 [cited 2022 Feb 9];8(3):e2690. Available from: https:\/\/journals.plos.org\/plosntds\/article?id=10.1371\/journal.pntd.0002690","DOI":"10.1371\/journal.pntd.0002690"},{"key":"13003_CR9","doi-asserted-by":"crossref","unstructured":"Saunderson P, Gebre S, Desta K, Byass P, Lockwood DNJ. The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome. Lepr Rev [Internet]. 2000 [cited 2022 Feb 9];71(3):285\u2013308. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11105488\/","DOI":"10.5935\/0305-7518.20000033"},{"key":"13003_CR10","unstructured":"World Health Organization. WHO Expert Committee on Leprosy. World Health Organ Tech Rep Ser. 2012;(968)."},{"key":"13003_CR11","doi-asserted-by":"crossref","unstructured":"Lambert SM, Alembo DT, Nigusse SD, Yamuah LK, Walker SL, Lockwood DNJ. A randomized controlled double blind trial of ciclosporin versus prednisolone in the management of leprosy patients with new type 1 reaction, in Ethiopia. PLoS Negl Trop Dis [Internet]. 2016 Apr 5 [cited 2022 Feb 9];10(4):e0004502. Available from: https:\/\/journals.plos.org\/plosntds\/article?id=10.1371\/journal.pntd.0004502","DOI":"10.1371\/journal.pntd.0004502"},{"issue":"2","key":"13003_CR12","first-page":"154","volume":"71","author":"RP Croft","year":"2000","unstructured":"Croft RP, Nicholls PG, Richardus JH, Smith WCS. The treatment of acute nerve function impairment in leprosy: Results from a prospective cohort study in Bangladesh. Lepr Rev. 2000;71(2):154\u201368.","journal-title":"Lepr Rev"},{"issue":"1","key":"13003_CR13","first-page":"8","volume":"61","author":"DNJ Lockwood","year":"1993","unstructured":"Lockwood DNJ, Vinayakumar S, Stanley JNA, McAdam KPWJ, Colston MJ. Clinical features and outcome of reversal (type 1) reactions in hyderabad, India. Int J Lepr. 1993;61(1):8\u201315.","journal-title":"Int J Lepr"},{"key":"13003_CR14","doi-asserted-by":"crossref","unstructured":"Garbino JA, Virmond MDCL, Ura S, Salgado MH, Naafs B. A randomized clinical trial of oral steroids for ulnar neuropathy in type 1 and type 2 leprosy reactions. Arq Neuropsiquiatr [Internet]. 2008 [cited 2022 Feb 9];66(4):861\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19099126\/","DOI":"10.1590\/S0004-282X2008000600016"},{"key":"13003_CR15","doi-asserted-by":"crossref","unstructured":"Kaur I, Dogra S, Narang T, De D. Comparative efficacy of thalidomide and prednisolone in the treatment of moderate to severe erythema nodosum leprosum: a randomized study. Australas J Dermatol [Internet]. 2009 Aug [cited 2022 Feb 9];50(3):181\u20135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19659979\/","DOI":"10.1111\/j.1440-0960.2009.00534.x"},{"issue":"2","key":"13003_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0004149","volume":"10","author":"SM Lambert","year":"2016","unstructured":"Lambert SM, Nigusse SD, Alembo DT, Walker SL, Nicholls PG, Idriss MH, et al. Comparison of Efficacy and Safety of Ciclosporin to Prednisolone in the Treatment of Erythema Nodosum Leprosum: Two Randomised, Double Blind, Controlled Pilot Studies in Ethiopia. PLoS Negl Trop Dis. 2016;10(2):1\u201318.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"13003_CR17","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/ard.61.8.718","volume":"61","author":"F Buttgereit","year":"2002","unstructured":"Buttgereit F, Da Silva JPA, Boers M, Burmester GR, Cutolo M, Jacobs J, et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: Current questions and tentative answers in rheumatology. Ann Rheum Dis. 2002;61(8):718\u201322.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"13003_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.47276\/lr.79.4.372","volume":"79","author":"SL Walker","year":"2008","unstructured":"Walker SL, Lockwood DNJ. Leprosy type 1 (reversal) reactions and their management. Lepr Rev. 2008;79(4):372\u201386.","journal-title":"Lepr Rev"},{"key":"13003_CR19","doi-asserted-by":"crossref","unstructured":"Shumet T, Demissie M, Bekele Y. Prevalence of disability and associated factors among registered leprosy patients in all Africa Tb and leprosy rehabilitation and training centre (ALERT), Addis Ababa, Ethiopia. Ethiop J Health Sci [Internet]. 2015 Oct 1 [cited 2022 Feb 9];25(4):313. Available from: http:\/\/www.pmc\/articles\/PMC4762969\/","DOI":"10.4314\/ejhs.v25i4.4"},{"key":"13003_CR20","doi-asserted-by":"crossref","unstructured":"Marlowe SNS, Leekassa R, Bizuneh E, Knuutilla J, Ale P, Bhattarai B et al. Response to ciclosporin treatment in Ethiopian and Nepali patients with severe leprosy Type 1 reactions. Trans R Soc Trop Med Hyg [Internet]. 2007 Oct 1 [cited 2022 Feb 9];101(10):1004\u201312. Available from: https:\/\/academic.oup.com\/trstmh\/article\/101\/10\/1004\/1895200","DOI":"10.1016\/j.trstmh.2006.11.010"},{"issue":"5","key":"13003_CR21","doi-asserted-by":"publisher","first-page":"868","DOI":"10.4269\/ajtmh.2006.74.868","volume":"74","author":"L Pocaterra","year":"2006","unstructured":"Pocaterra L, Jain S, Reddy R, Muzaffarullah S, Torres O, Suneetha S, et al. Clinical course of erythema nodosum leprosum: An 11-year cohort study in Hyderabad, India. Am J Trop Med Hyg. 2006;74(5):868\u201379.","journal-title":"Am J Trop Med Hyg"},{"key":"13003_CR22","doi-asserted-by":"crossref","unstructured":"Van Veen NHJ, Nicholls PG, Smith WCS, Richardus JH. Corticosteroids for treating nerve damage in leprosy. Cochrane Database Syst Rev. 2016;2016(5).","DOI":"10.1002\/14651858.CD005491.pub3"},{"issue":"3","key":"13003_CR23","first-page":"255","volume":"34","author":"DS Ridley","year":"1966","unstructured":"Ridley DS, Jopling WH. Classification of leprosy according to immunity. Int J Lepr. 1966;34(3):255\u201373.","journal-title":"Int J Lepr"},{"key":"13003_CR24","unstructured":"Saba M. Lambert. Assessing ciclosporin in the treatment of leprosy reactions: evidence from a randomized controlled trial and other studies. PhD thesis, London School of Hygiene & Tropical Medicine; 2014."},{"key":"13003_CR25","first-page":"308","volume":"71","author":"P Saunderson","year":"2000","unstructured":"Saunderson P, Gebre S, Desta K, Byass P, Lockwood DNJ. The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome. Lepr Rev. 2000;71:308\u201317.","journal-title":"Lepr Rev"},{"key":"13003_CR26","doi-asserted-by":"crossref","unstructured":"Wagenaar I, Post E, Brandsma W, Bowers B, Alam K, Shetty V et al. Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: a randomized controlled trial. PLoS Negl Trop Dis. 2017;11(10).","DOI":"10.1371\/journal.pntd.0005952"},{"issue":"1","key":"13003_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.47276\/lr.77.1.25","volume":"77","author":"PSS Sundar Rao","year":"2006","unstructured":"Sundar Rao PSS, Sugamaran DST, Richard J, Smith WCS. Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy. Lepr Rev. 2006;77(1):25\u201333.","journal-title":"Lepr Rev"},{"key":"13003_CR28","doi-asserted-by":"crossref","unstructured":"Fardet L, Flahault A, Kettaneh A, Tiev KP, G\u00e9n\u00e9reau T, Tol\u00e9dano C et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient\u2019s opinion. Br J Dermatol [Internet]. 2007 Jul [cited 2022 Feb 9];157(1):142\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17501951\/","DOI":"10.1111\/j.1365-2133.2007.07950.x"},{"key":"13003_CR29","doi-asserted-by":"crossref","unstructured":"Walker SL, Nicholls PG, Dhakal S, Hawksworth RA, Macdonald M, Mahat K et al. A phase two randomised controlled double blind trial of high dose intravenous Methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and\/or nerve function impairment. PLoS Negl Trop Dis. 2011;5(4).","DOI":"10.1371\/journal.pntd.0001041"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13003-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13003-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13003-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:13:47Z","timestamp":1776327227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13003-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13003"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13003-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"6 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and was approved by St Paul\u2019s Hospital Millennium Medical College Ethics committee and ALERT Hospital. Since the study was retrospective\/Chart review and the individual are not accessible waiver of consent was obtained. All potential identifiers were removed from the format to ensure privacy and confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"771"}}